01/03/2021 (Agence Europe) – The European Commission approved, on Friday 26 February, an Italian State Aid of €40 million for coronavirus related research and development (R&D). These activities are carried out by the biotechnology company ReiThera S.r.l. This measure has been authorised under the State aid Temporary Framework. Public support will take the form of a direct grant. The aim of the measure is to support the development of a novel coronavirus vaccine. The measure will...